These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7827256)

  • 1. Comparison of the effects of carnitine palmitoyltransferase-1 and -2 inhibitors on rat heart hypertrophy.
    Hülsmann WC; Peschechera A; Schneijdenberg CT; Verkleij AJ
    Cardioscience; 1994 Sep; 5(3):193-7. PubMed ID: 7827256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.
    Luiken JJ; Niessen HE; Coort SL; Hoebers N; Coumans WA; Schwenk RW; Bonen A; Glatz JF
    Biochem J; 2009 Apr; 419(2):447-55. PubMed ID: 19138173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial protection from ischemic preconditioning is not blocked by sub-chronic inhibition of carnitine palmitoyltransferase I.
    Penna C; Mancardi D; Gattullo D; Pagliaro P
    Life Sci; 2005 Sep; 77(16):2004-17. PubMed ID: 15919095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle.
    Reinauer H; Adrian M; Rösen P; Schmitz FJ
    J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation and excretion of long-chain acylcarnitine by rat hearts; studies with aminocarnitine.
    Hülsmann WC; Schneijdenberg CT; Verkleij AJ
    Biochim Biophys Acta; 1991 Nov; 1097(4):263-9. PubMed ID: 1742330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
    Schmitz FJ; Rösen P; Reinauer H
    Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional studies of yeast-expressed human heart muscle carnitine palmitoyltransferase I.
    Zhu H; Shi J; de Vries Y; Arvidson DN; Cregg JM; Woldegiorgis G
    Arch Biochem Biophys; 1997 Nov; 347(1):53-61. PubMed ID: 9344464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivatives of R-aminocarnitine without ammonium moiety as liver carnitine palmitoyltransferase I (L-CPT I) inhibitors.
    Tassoni E; Conti R; Gallo G; Vincenti S; Mastrofrancesco L; Brunetti T; Cabri W; Giannessi F
    ChemMedChem; 2011 Nov; 6(11):1977-80. PubMed ID: 21834096
    [No Abstract]   [Full Text] [Related]  

  • 9. Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity.
    Giannessi F; Pessotto P; Tassoni E; Chiodi P; Conti R; De Angelis F; Dell'Uomo N; Catini R; Deias R; Tinti MO; Carminati P; Arduini A
    J Med Chem; 2003 Jan; 46(2):303-9. PubMed ID: 12519067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
    Holness MJ; Priestman DA; Sugden MC
    J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of carnitine palmitoyltransferase-I gene isoforms (CPT-I alpha and CPT-I beta) in the rat heart.
    Cook GA; Edwards TL; Jansen MS; Bahouth SW; Wilcox HG; Park EA
    J Mol Cell Cardiol; 2001 Feb; 33(2):317-29. PubMed ID: 11162136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.
    Bentebibel A; Sebastián D; Herrero L; López-Viñas E; Serra D; Asins G; Gómez-Puertas P; Hegardt FG
    Biochemistry; 2006 Apr; 45(14):4339-50. PubMed ID: 16584169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of etomoxiryl-CoA on different carnitine acyltransferases.
    Lilly K; Chung C; Kerner J; VanRenterghem R; Bieber LL
    Biochem Pharmacol; 1992 Jan; 43(2):353-61. PubMed ID: 1739421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir.
    Lopaschuk GD; McNeil GF; McVeigh JJ
    Mol Cell Biochem; 1989 Jun 27-Jul 24; 88(1-2):175-9. PubMed ID: 2779537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Tetradecylglycidic acid, an inhibitor of carnitine palmitoyltransferase-1, induces myocardial hypertrophy via the AT1 receptor.
    Wolkowicz PE; Urthaler F; Forrest C; Shen H; Durand J; Wei CC; Oparil S; Dell'Italia LJ
    J Mol Cell Cardiol; 1999 Aug; 31(8):1405-12. PubMed ID: 10424880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of inhibitors of carnitine palmitoyltransferase I and fibrates in cultured hepatocytes.
    Gerondaes P; Alberti KG; Agius L
    Biochem J; 1988 Jul; 253(1):169-73. PubMed ID: 3421940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue lipid accumulation by L-aminocarnitine, an inhibitor of carnitine-palmitoyltransferase-2. Studies in intact rats and isolated mitochondria.
    Chiodi P; Maccari F; Ramacci MT
    Biochim Biophys Acta; 1992 Jul; 1127(1):81-6. PubMed ID: 1627637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic modulators, Etomoxir and NVP-LAB121, fail to reverse pressure overload induced heart failure in vivo.
    Schwarzer M; Faerber G; Rueckauer T; Blum D; Pytel G; Mohr FW; Doenst T
    Basic Res Cardiol; 2009 Sep; 104(5):547-57. PubMed ID: 19294446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats.
    Yoon HR; Hong YM; Boriack RL; Bennett MJ
    Pediatr Res; 2003 May; 53(5):788-92. PubMed ID: 12621117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.